These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1083659)

  • 1. Interference with antibody-feedback by irradiation, thymus cells, the allogeneic effect, and serum factors.
    Sinclair NR; Lees RK; Chan PL
    Adv Exp Med Biol; 1976; 66():623-33. PubMed ID: 1083659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective suppression of immune responses. Regulation of antibody formation and cell-mediated immunity by antibody.
    Fitch FW
    Prog Allergy; 1975; 19():195-244. PubMed ID: 56009
    [No Abstract]   [Full Text] [Related]  

  • 3. Alloantiserum-mediated suppression of histocompatibility-linked Ir-gene-controlled immune responses. Suppressive effects of IgG fragments derived from alloantisera.
    Bluestein HG
    J Exp Med; 1974 Aug; 140(2):481-93. PubMed ID: 4846415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the immune response. IX. Resistance to antibody mediated immunosuppression induced by the presence of the allogeneic effect.
    Lees RK; Sinclair NR
    Cell Immunol; 1975 Jun; 17(2):525-31. PubMed ID: 1092484
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of the immune response by 7S antibody mechanism and site of action.
    Abrahams S; Phillips RA; Miller RG
    J Exp Med; 1973 Apr; 137(4):870-92. PubMed ID: 4576501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the immune response. VI. Inability of F(ab') 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression.
    Chan PL; Sinclair NR
    Immunology; 1973 Feb; 24(2):289-301. PubMed ID: 4576780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of Fc receptors with antibodies against Ia antigens and other cell surface components.
    Schirrmacher V; Halloran P; David CS
    J Exp Med; 1975 May; 141(5):1201-9. PubMed ID: 1079233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody and cell requirements for cytotoxicity by non-immune effector cells.
    Gelfand EW; Resch K
    Adv Exp Med Biol; 1973; 29(0):581-8. PubMed ID: 4604104
    [No Abstract]   [Full Text] [Related]  

  • 9. Hapten-IgG-induced suppression of the in vitro antibody response: role of hapten density and of antigenic challenge.
    Galanaud P; Crevon MC; Erard D; Dormont J
    Cell Immunol; 1977 Mar; 29(1):72-85. PubMed ID: 321138
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of immunity by antibody, antigen-antibody complexes and antigen.
    Sinclair NR
    Pharmacol Ther; 1979; 4(2):355-432. PubMed ID: 386386
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological enhancement of a murine tumor allograft by passive alloantibody IgG and F(ab')2.
    Kaliss N; Sinclair NR; Cantrell JL
    Eur J Immunol; 1976 Jan; 6(1):38-42. PubMed ID: 971718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the antibody response to SRBC with F(ab') 2 and IgG in vitro.
    Wason WM; Fitch FW
    J Immunol; 1973 May; 110(5):1427-9. PubMed ID: 4572635
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody-mediated immunosuppression of a cytotoxic cell response not involving a simple antigen-masking mechanism.
    Sinclair NR; Law FY
    J Immunol; 1979 Oct; 123(4):1439-44. PubMed ID: 479591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to phosphorylcholine. III. Requirement of the Fc portion and equal effectiveness of IgG subclasses in anti-receptor antibody-induced suppression.
    Köhler H; Richardson BC; Rowley DA; Smyk S
    J Immunol; 1977 Dec; 119(6):1979-86. PubMed ID: 915288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of Fab fragments of anti-human immunoglobulin as analytic tools for establishing the involvement of immunoglobulin in the spontaneous cytotoxicity to cultured tumor cells by lymphocytes from patients with bladder carcinoma and from healthy donors.
    Troye M; Perlmann P; Pape GR; Spiegelberg HL; Näslund I; Gidlöf A
    J Immunol; 1977 Sep; 119(3):1061-7. PubMed ID: 302271
    [No Abstract]   [Full Text] [Related]  

  • 18. Two distinct mechanisms of immune suppression by antibody.
    Hoffmann MK; Kappler JW
    Nature; 1978 Mar; 272(5648):64-5. PubMed ID: 75510
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells.
    Saal JG; Rieber EP; Hadam M; Riethmuller G
    Nature; 1977 Jan; 265(5590):158-60. PubMed ID: 299919
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of T lymphocytes by the Fc portion of immunoglobulin.
    Thoman ML; Morgan EL; Weigle WO
    J Supramol Struct; 1980; 13(4):479-88. PubMed ID: 6971961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.